Phoenix Biotech Acquisiti...

NASDAQ: PBAX · Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 9:56 PM

Phoenix Biotech Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.33M 475.87K 1.1M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a 178.5M
Other Long-Term Assets
500K n/a 147.71K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
386.98K 225.19K 262.5K
Total Current Assets
3.71M 42.37M 1.36M
Property-Plant & Equipment
1.99M n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
2.49M n/a 178.72M
Total Assets
6.21M 42.37M 180.08M
Account Payables
4.51M 1.65M 14.43K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
876.39K 650K n/a
Other Current Liabilities
2.02M 28.45M 83.64K
Total Current Liabilities
7.4M 30.75M 98.07K
Long-Term Debt
699.11K n/a n/a
Other Long-Term Liabilities
n/a 9.15M n/a
Total Long-Term Liabilities
699.11K 9.15M 9.15M
Total Liabilities
8.1M 39.9M 9.25M
Total Debt
1.58M 650K n/a
Common Stock
85.74K 13.22M 178.5M
Retained Earnings
-70.92M -10.76M -7.67M
Comprehensive Income
n/a n/a 178.5M
Shareholders Equity
-1.89M 2.47M 170.83M
Total Investments
n/a n/a 178.5M